Who invested in Atai Life Sciences

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$68Mraised across 2 rounds since 2018, from 2 sources

$25MRound$43MSeries B

Latest round: Series B, $43MMar 2019
Step-upi: 1.7×
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019

$25MRound$43MSeries B

First round: Round, $25M
Biggest round: $43M
Between rounds: 6 months

The rounds

Mar 2019
Series B$43M4 new
- Subversive Capital
- Apeiron
- Bail
- Efrem Kamen
Reported by FinSMEs
Oct 2018
Round$25M3 new
- Peter Thiel
- Mike Novogratz
- Thor Bjorgolfsson
Reported by Businessinsider

Founders and team

From Atai Life Sciences's own website: 1 founder, 6 on the team.

Christian AngermayerFounder and Chairman of the Board

Anne JohnsonChief Accounting Officer
Michael FaermChief Financial Officer
Ryan BarrettChief Legal and Business Officer
Andrea Heslin SmileyDirector
John HoffmanDirector
Sabrina Martucci JohnsonDirector

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Series B2019Peter Thiel

Subversive Capital

ApeironBailEfrem KamenMike NovogratzThor Bjorgolfsson

Everyone who backed them

Peter ThielAngel1round

Subversive CapitalVC firm1round

ApeironPrivate equity1round

Bailno record of our own yet1round

Efrem Kamenno record of our own yet1round

Mike Novogratzno record of our own yet1round

Thor Bjorgolfssonno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 20 firms list Atai Life Sciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.